跳至主要内容
临床试验/IRCT20210803052067N1
IRCT20210803052067N1已完成3 期

Evaluation of bone density changes before and after administration of at least one year of danozoomab in patients referred to Imam Reza Hospital

Artesh University of Medical Sciences0 个研究点目标入组 202 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
202

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
45 years 至 75 years(—)
性别
Female

入选标准

  • Postmenopausal women (aged 45 to 75 years old) diagnosed with osteoporosis by densitometry via Dexa(dual energy Xray absorptiometry).

排除标准

  • Lack of consent for being in the trial
  • Having hypersensitivity to denosumab or any component in the formulation
  • Malabsorption syndrome
  • History of thyroid surgery, parathyroid surgery or intestinal resection which has been caused malabsorption Patient

研究者

发起方
Artesh University of Medical Sciences

相似试验